FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

377315004: Codeine phosphate + pseudoephedrine hydrochloride + triprolidine hydrochloride 10mg/30mg/1.25mg liquid (product)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2638999012 Codeine phosphate + pseudoephedrine hydrochloride + triprolidine hydrochloride 10mg/30mg/1.25mg liquid (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2642978015 Codeine phosphate+pseudoephedrine hydrochloride+triprolidine hydrochloride 10mg/30mg/1.25mg liquid en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3084847010 Codeine phosphate + pseudoephedrine hydrochloride + triprolidine hydrochloride 10mg/30mg/1.25mg liquid en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Codeine phosphate + pseudoephedrine hydrochloride + triprolidine hydrochloride 10mg/30mg/1.25mg liquid Is a Product containing codeine phosphate false Inferred relationship Some
    Codeine phosphate + pseudoephedrine hydrochloride + triprolidine hydrochloride 10mg/30mg/1.25mg liquid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Codeine phosphate false Inferred relationship Some
    Codeine phosphate + pseudoephedrine hydrochloride + triprolidine hydrochloride 10mg/30mg/1.25mg liquid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Morphinan opioid false Inferred relationship Some
    Codeine phosphate + pseudoephedrine hydrochloride + triprolidine hydrochloride 10mg/30mg/1.25mg liquid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Codeine (substance) false Inferred relationship Some
    Codeine phosphate + pseudoephedrine hydrochloride + triprolidine hydrochloride 10mg/30mg/1.25mg liquid Is a Codeine phosphate + pseudoephedrine hydrochloride + triprolidine hydrochloride false Inferred relationship Some
    Codeine phosphate + pseudoephedrine hydrochloride + triprolidine hydrochloride 10mg/30mg/1.25mg liquid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Central nervous system agent (substance) false Inferred relationship Some
    Codeine phosphate + pseudoephedrine hydrochloride + triprolidine hydrochloride 10mg/30mg/1.25mg liquid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Triprolidine hydrochloride false Inferred relationship Some
    Codeine phosphate + pseudoephedrine hydrochloride + triprolidine hydrochloride 10mg/30mg/1.25mg liquid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Pseudoephedrine hydrochloride false Inferred relationship Some
    Codeine phosphate + pseudoephedrine hydrochloride + triprolidine hydrochloride 10mg/30mg/1.25mg liquid Has manufactured dose form Oral liquid false Inferred relationship Some
    Codeine phosphate + pseudoephedrine hydrochloride + triprolidine hydrochloride 10mg/30mg/1.25mg liquid Is a Codeine-containing product in oral dose form false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    Description inactivation indicator reference set

    Back to Start